Peter Sazani

3.6k total citations
36 papers, 2.2k citations indexed

About

Peter Sazani is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Peter Sazani has authored 36 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 8 papers in Genetics and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Peter Sazani's work include Muscle Physiology and Disorders (15 papers), RNA Interference and Gene Delivery (13 papers) and Advanced biosensing and bioanalysis techniques (10 papers). Peter Sazani is often cited by papers focused on Muscle Physiology and Disorders (15 papers), RNA Interference and Gene Delivery (13 papers) and Advanced biosensing and bioanalysis techniques (10 papers). Peter Sazani collaborates with scholars based in United States, Thailand and China. Peter Sazani's co-authors include Ryszard Kole, Martin A. Maier, Muthiah Manoharan, Jack W. Szostak, Hong M. Moulton, Jennifer Roberts, Natee Jearawiriyapaisarn, Patrick L. Iversen, Joseph M. DeSimone and R. Jude Samulski and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Peter Sazani

36 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Sazani United States 25 1.9k 319 206 163 145 36 2.2k
Rudolph L. Juliano United States 30 2.4k 1.3× 221 0.7× 79 0.4× 243 1.5× 191 1.3× 56 2.9k
Hyun-Seo Kang Germany 18 970 0.5× 120 0.4× 160 0.8× 94 0.6× 58 0.4× 30 1.4k
Klaus Charissé United States 30 3.4k 1.8× 233 0.7× 46 0.2× 263 1.6× 355 2.4× 56 3.9k
Amir K. Varkouhi Netherlands 12 1.4k 0.7× 216 0.7× 76 0.4× 592 3.6× 498 3.4× 17 2.0k
Kentaro Takayama Japan 22 1.0k 0.6× 226 0.7× 46 0.2× 182 1.1× 77 0.5× 88 1.6k
June Qin United States 11 1.6k 0.8× 197 0.6× 44 0.2× 207 1.3× 156 1.1× 19 1.8k
Maria Lindgren Sweden 17 2.0k 1.1× 300 0.9× 56 0.3× 315 1.9× 125 0.9× 31 2.3k
Mark A. Tracy United States 13 1.3k 0.7× 151 0.5× 27 0.1× 287 1.8× 235 1.6× 14 1.9k
Meir Goldsmith Israel 22 1.4k 0.7× 182 0.6× 28 0.1× 455 2.8× 391 2.7× 35 2.0k
Kotaro Hayashi Japan 21 748 0.4× 95 0.3× 62 0.3× 336 2.1× 256 1.8× 75 1.5k

Countries citing papers authored by Peter Sazani

Since Specialization
Citations

This map shows the geographic impact of Peter Sazani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Sazani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Sazani more than expected).

Fields of papers citing papers by Peter Sazani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Sazani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Sazani. The network helps show where Peter Sazani may publish in the future.

Co-authorship network of co-authors of Peter Sazani

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Sazani. A scholar is included among the top collaborators of Peter Sazani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Sazani. Peter Sazani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heald, Alison E., Jay S. Charleston, Patrick L. Iversen, et al.. (2015). AVI-7288 for Marburg Virus in Nonhuman Primates and Humans. New England Journal of Medicine. 373(4). 339–348. 40 indexed citations
2.
3.
Kaye, Edward M., Jerry R. Mendell, Louise R. Rodino‐Klapac, et al.. (2014). Results at 96 Weeks of a Phase IIb Extension Study of the Exon-Skipping Drug Eteplirsen in Patients with Duchenne Muscular Dystrophy (DMD) (S6.002). Neurology. 82(10_supplement). 1 indexed citations
4.
Bauman, John A., et al.. (2013). Oligonucleotide Therapeutics in Cancer. Cancer treatment and research. 158. 213–233. 16 indexed citations
5.
6.
Sazani, Peter, Doreen L. Weller, & Stephen B. Shrewsbury. (2010). Safety Pharmacology and Genotoxicity Evaluation of AVI-4658. International Journal of Toxicology. 29(2). 143–156. 36 indexed citations
7.
Moulton, Hong M., Bo Wu, Natee Jearawiriyapaisarn, et al.. (2009). Peptide‐Morpholino Conjugate: A Promising Therapeutic for Duchenne Muscular Dystrophy. Annals of the New York Academy of Sciences. 1175(1). 55–60. 28 indexed citations
8.
Jearawiriyapaisarn, Natee, Hong M. Moulton, Peter Sazani, Ryszard Kole, & Monte S. Willis. (2009). Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers†. Cardiovascular Research. 85(3). 444–453. 67 indexed citations
9.
Jearawiriyapaisarn, Natee, Hong M. Moulton, Brian K. Buckley, et al.. (2008). Sustained Dystrophin Expression Induced by Peptide-conjugated Morpholino Oligomers in the Muscles of mdx Mice. Molecular Therapy. 16(9). 1624–1629. 187 indexed citations
10.
Graziewicz, Maria A, Teresa K. Tarrant, Brian K. Buckley, et al.. (2008). An Endogenous TNF-α Antagonist Induced by Splice-switching Oligonucleotides Reduces Inflammation in Hepatitis and Arthritis Mouse Models. Molecular Therapy. 16(7). 1316–1322. 51 indexed citations
11.
Sazani, Peter, et al.. (2008). Modification of HER2 pre‐mRNA alternative splicing and its effects on breast cancer cells. International Journal of Cancer. 124(4). 772–777. 32 indexed citations
12.
Chen, Irene A., Martin M. Hanczyc, Peter Sazani, & Jack W. Szostak. (2006). 3 Protocells: Genetic Polymers Inside Membrane Vesicles. Cold Spring Harbor Monograph Archive. 43. 57–88. 22 indexed citations
13.
Sazani, Peter & Ryszard Kole. (2003). Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing. Journal of Clinical Investigation. 112(4). 481–486. 168 indexed citations
14.
Sazani, Peter & Ryszard Kole. (2003). Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing. Journal of Clinical Investigation. 112(4). 481–486. 165 indexed citations
15.
Sazani, Peter, et al.. (2003). Effects of Base Modifications on Antisense Properties of 2′- O -Methoxyethyl and PNA Oligonucleotides. Antisense and Nucleic Acid Drug Development. 13(3). 119–128. 27 indexed citations
16.
Sazani, Peter, et al.. (2002). Short-term and long-term modulation of gene expression by antisense therapeutics. Current Opinion in Biotechnology. 13(5). 468–472. 25 indexed citations
17.
Sazani, Peter, Federica Gemignani, Martin A. Maier, et al.. (2002). Systemically delivered antisense oligomers upregulate gene expression in mouse tissues. Nature Biotechnology. 20(12). 1228–1233. 246 indexed citations
18.
Sazani, Peter, Martin A. Maier, Changfu Wei, et al.. (2001). Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs. Nucleic Acids Research. 29(19). 3965–3974. 174 indexed citations
19.
Mercatante, Danielle R., et al.. (2001). Modification of Alternative Splicing by Antisense Oligonucleotides as a Potential Chemotherapy for Cancer and Other Diseases. Current Cancer Drug Targets. 1(3). 211–230. 41 indexed citations
20.
Sazani, Peter, et al.. (1999). PAMAM Dendrimers as Delivery Agents for Antisense Oligonucleotides. Pharmaceutical Research. 16(12). 1799–1804. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rudolph L. Juliano Breakdown of academic impact, for papers by Hyun-Seo Kang Breakdown of academic impact, for papers by Klaus Charissé Breakdown of academic impact, for papers by Amir K. Varkouhi Breakdown of academic impact, for papers by Kentaro Takayama Breakdown of academic impact, for papers by June Qin Breakdown of academic impact, for papers by Maria Lindgren Breakdown of academic impact, for papers by Mark A. Tracy Breakdown of academic impact, for papers by Meir Goldsmith Breakdown of academic impact, for papers by Kotaro Hayashi
Rankless by CCL
2026